$JNJ Johnson Johnson (JNJ) 92.65 +0.48 (+0.52%) Past
$JNJ
Johnson & Johnson (JNJ)
92.65 +0.48 (+0.52%)
Past 5 Days
Date Open High Low Last Change % Change Volume
02/19/14 92.15 92.75 91.66 92.65 +0.48 +0.52% 962,654
02/18/14 92.77 92.85 92.09 92.17 -0.59 -0.64% 6,934,300
02/14/14 92.60 92.95 92.03 92.76 +0.20 +0.22% 5,524,600
02/13/14 92.00 92.62 91.71 92.56 +0.14 +0.15% 5,926,300
02/12/14 92.95 92.99 91.95 92.42 -0.55 -0.59% 7,699,300
Historical Highs and Lows
-- Period -- -- High -- -- Low -- -- Percent Change --
5-Day 92.95 on 02/14/14 91.66 on 02/19/14 unch since 02/12/14
1-Month 95.10 on 01/21/14 86.09 on 02/04/14 -2.78% since 01/17/14
3-Month 95.99 on 11/25/13 86.09 on 02/04/14 -2.57% since 11/19/13
6-Month 95.99 on 11/25/13 85.50 on 10/09/13 +2.18% since 08/19/13
12-Month 95.99 on 11/25/13 75.50 on 02/26/13 +20.09% since 02/19/13
Year to Date 95.38 on 01/09/14 86.09 on 02/04/14 +0.91% since 12/31/13
New Highs and Lows
For The Last Made New High Percent From Made New Low Percent From
5-Day 2 times -0.57% 2 times +0.83%
1-Month 1 time -2.82% 9 times +7.35%
3-Month 3 times -3.72% 13 times +7.35%
6-Month 14 times -3.72% 9 times +8.09%
12-Month 52 times -3.72% 5 times +22.41%
Year to Date 5 times -3.10% 8 times +7.35%
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...
Continue Reading
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...
Continue Reading
Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...
Continue Reading
Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...
Continue Reading
Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...
Continue Reading
Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...
Continue Reading
A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...
Continue Reading
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue Reading
Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...
Continue Reading
Top 5 Most Recently Viewed Articles
Columbus McKinnon Completes Important Notes Offering Columbus McKinnon Corporation (NASDAQ: CMCO), a prominent designer and manufacturer in the intelligent motion solutions sector, has successfully completed a notable offering of senior secured notes. This offering totaled $900 million with a set interest rate of 7.125%, maturing in 2033, aimed at supporting the company's...
Continue Reading
Rollin' into Earnings: What to Expect from TMDX Every now and then, a company catches wind in its sails, and TransMedics Gr (NASDAQ:TMDX)—well, it’s been riding a decent wave lately. With earnings about to drop on February 24, 2026, folks are buzzing, holding their breath, and looking for that golden info nugget to drop. Analysts are pinning their hopes on an earnings...
Continue Reading
Rigel Pharmaceuticals Gears Up for J.P. Morgan Healthcare Conference Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a prominent name in biotechnology focused on hematologic disorders and cancer treatments, is poised to make a significant impact at the upcoming J.P. Morgan Healthcare Conference. The event is set to bring together industry leaders and innovators, making it an...
Continue Reading
Exciting Updates from Big Lots This Holiday Season Big Lots is gearing up for the holiday season with some thrilling news for all shoppers. The launch of their new Holiday Shop is set to delight customers, combined with an unforgettable one-day shopping event called ‘Falloweenmas’ which offers great savings and unique decorations for this festive time of year....
Continue Reading
Amcor Announces New Leadership with Stephen R. Scherger Amcor, a global frontrunner in packaging solutions, has appointed Stephen R. Scherger as its new Executive Vice President and Chief Financial Officer, effective November 10, 2025. This decision comes as the current CFO, Michael Casamento, steps down after dedicating a decade to the company. He will continue in an...
Continue Reading